Holen Sie sich die Stockscreener-App
2.70
1.46%
-0.04
Handel nachbörslich:
2.70
Schlusskurs vom Vortag:
$2.74
Offen:
$2.71
24-Stunden-Volumen:
126.33K
Relative Volume:
0.86
Marktkapitalisierung:
$101.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.27M
KGV:
-16.46
EPS:
-0.164
Netto-Cashflow:
$-7.70M
1W Leistung:
+1.89%
1M Leistung:
+31.71%
6M Leistung:
+98.17%
1J Leistung:
+125.00%
1-Tages-Spanne:
$2.58
$2.79
1-Wochen-Bereich:
$2.50
$2.83
52-Wochen-Spanne:
$0.9016
$3.349
Okyo Pharma Limited Stock (OKYO) Company Profile
Firmenname
Okyo Pharma Limited
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie OKYO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.70 | 103.05M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Okyo Pharma Limited Aktie (OKYO) Neueste Nachrichten
Will OKYO Pharma Limited (OK11) stock profit from automation waveLayoff News & Smart Swing Trading Techniques - newser.com
What sentiment indicators say about OKYO Pharma Limited stock2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
How OKYO Pharma Limited (OK11) stock reacts to fiscal policiesDay Trade & Low Risk Investment Opportunities - newser.com
Long term hold vs stop loss in OKYO Pharma LimitedJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - newser.com
Will OKYO Pharma Limited stock benefit from commodity prices2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com
How OKYO Pharma Limited stock valuations compare to rivalsJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
Will OKYO Pharma Limited stock deliver better than expected guidanceJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com
Will OKYO Pharma Limited (OK11) stock enhance shareholder valueGap Down & Weekly High Potential Alerts - newser.com
Is OKYO Pharma Limited stock safe for conservative investorsJuly 2025 Action & Fast Exit and Entry Strategy Plans - newser.com
What technical signals suggest for OKYO Pharma Limited stockJuly 2025 Breakouts & Safe Swing Trade Setups - newser.com
Individual investors invested in OKYO Pharma Limited (NASDAQ:OKYO) up 16% last week, insiders too were rewarded - simplywall.st
Key metrics from OKYO Pharma Limited’s quarterly dataQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Is OKYO Pharma Limited a candidate for recovery playWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
Will OKYO Pharma Limited (OK11) stock announce a stock split2025 Volatility Report & Technical Entry and Exit Tips - newser.com
Will OKYO Pharma Limited stock outperform Nasdaq index2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com
Market reaction to OKYO Pharma Limited’s recent news2025 Trading Recap & High Accuracy Trade Signal Alerts - newser.com
Strategies to average down on OKYO Pharma Limited2025 Fundamental Recap & Verified Short-Term Plans - newser.com
Is OKYO Pharma Limited building a consolidation baseJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
OKYO Pharma CEO to present at BIO-Europe conference in Vienna By Investing.com - Investing.com South Africa
OKYO Pharma CEO to present at BIO-Europe conference in Vienna - Investing.com UK
OKYO Pharma to present positive Phase 2 Data for urcosimod at BIO-Europe 2025 - Proactive financial news
OKYO Pharma to Present at BIO-Europe 2025 Highlighting Urcosimod Progress - TipRanks
OKYO Pharma to Present at BIO-Europe 2025 in Vienna - The Manila Times
Finanzdaten der Okyo Pharma Limited-Aktie (OKYO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):